AlzheimersDiseaseLibrary

Alzheimer’s disease is difficult to diagnose. Still today, the only certain method of diagnosis of Alzheimer’s is through brain biopsy performed after death of patient. What are needed are a forward-looking tests and markers …
With patients living, working methods acceptable for the diagnosis of Alzheimer’s by process of elimination.
Researchers have worked hard to develop methods and markers specific for early detection and early Alzheimer’s process of nerve degeneration.

There was significant progress made in the area of Alzheimer’s diagnosis. Have been discovered genetic indicators, biomarkers are being developed and a brain scan technology continues to improve. A team at the translational Genomics Research Institute in Phoenix, Arizona, has discovered a gene called GAB2. If you have a corrupted version that you are a much higher risk of eventually developing Alzheimer’s.

This can ultimately help us to diagnose Alzheimer’s disease even before it started. Biomarkers. Nanogen, Inc., a San Diego, CA-based advanced technology, working to provide researchers, doctors and physicians with a method that has been repaired and tools to predict, diagnose, and ultimately help treat disease. In early 2007 they announced that it had received two patents relating to the identification of protein biomarkers for Alzheimer’s disease.

Brain scan tests, such as computerized tomography (CT) scan, (the most widely used), Magnetic Resonance Imaging (MRI) scans, or positron emission tomography (PET), Single Photon Emission together with CT (sect) is now used.
Hopefully we’ll soon have better methods for early diagnosis and treatment of Alzheimer’s.